Ultrasound diagnosis and monitoring of fetal tachyarrhythmias

 Yu.А. Ivaniv, N.V. Lozynska

References 

1. Donofrio MT, Moon-Grady AJ, Hornberger LK. et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014;129(21):2183-2242.
2. Gembruch U. Fetal tachyarrythmia. In Fetal Cardiology. Eds. Yagel S, Silverman NH, Gembruch U. 2nd ed. Informa healscare, 2008:461-481.
3. Hornberger LK. Echocardiographic assessment of fetal arrhythmias. Heart. 2007;93:1331-1333.
4. Jaeggi ET, Carvalho JS, De Groot E. et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011;124 (16):1747-1754.
5. Kothari DS, Skinner JR. Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal. Ed. 2006;91:136-144.
6. Merriman JB, Gonzalez JM, Rychik J, Ural SH. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report. J Reprod Med. 2008;53(5):357-359.
7. Respondek-Liberska M. Czestoskurcz plodu. Kardiologia prenatalna dla poloznikow i kardiologow dzieciecych. 2006;12:115-123.
8. Shah A, Moon-Grady A, Bhogal N. et al. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias. Am J Cardiol. 2012;109(11):1614-1648.
9. Strasburger JF, Wakai RT. Fetal cardiac arrhythmia detection and in utero therapy. Nat Rev Cardiol. 2010;7 (5):277-290.
10. Van den Heuvel F, Bink-Boelkens MT, du Marchie Sarvaas, Berger RM. Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach? Pacing Clin Electrophysiol. 2008;31:54-57.
11. Wacker-Gussmann A, Strasburger JF, Cuneo BF, Wakai RT. Diagnosis and treatment of fetal arrhysmia. Am J Perinatol. 2014;31(7):617-628.
12. Weber R, Stambach D, Jaeggi E. Diagnosis and management of common fetal arrhythmias. J Saudi Heart Association. 2011;23:61-66.